Literature DB >> 23529453

Adverse drug reactions - allergy? side-effect? intolerance?

William Smith1.   

Abstract

BACKGROUND: Adverse drug reactions (ADRs) vary from life-threatening anaphylaxis to minor common side-effects.
OBJECTIVE: To provide an overview on the assessment of ADRs. To discuss the features of what may be described as a 'reaction to a drug' in order to highlight those suggestive of allergy, side-effect or intolerance, and what implications this might have for the future use or avoidance of the drug. DISCUSSION: Assessment of an ADR may apply to a current reaction or a history of a past reaction. The main decision is whether to cease the drug and/or whether it can be used again. Some ADRs are serious and likely to be reproducible and constitute absolute contraindications, whereas others are mild and may or may not occur on subsequent exposure. The mechanism of the ADR may be helpful in risk assessment. Drug allergy has immunological mechanisms: it may be severe, tends to be reproducible and may cross-react with structurally related drugs. Drug side-effects are more common and predictable, vary in severity and depend on the drug's pharmacological action. Intolerance tends to be less severe, and may depend on susceptibility factors, which can vary. The decision to prescribe a drug where there is a history of a previous ADR requires careful assessment of the risks and potential benefits.

Entities:  

Mesh:

Year:  2013        PMID: 23529453

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  7 in total

Review 1.  In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.

Authors:  Abdelbaset A Elzagallaai; Michael J Rieder
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

2.  Erythema multiforme after treatment with sorafenib.

Authors:  Aaminah Faheem Azhar; Rachael Camille Saporito; Jordan Jamerson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-03-08

3.  Barriers to Medication Review Process Implementation-Cross-Sectional Study among Community Pharmacists in Jordan.

Authors:  Mohammad Abu Assab; Hamza Alhamad; Inas Almazari; Bilyana Azzam; Hanadi Abu Assab
Journal:  Healthcare (Basel)       Date:  2022-03-31

Review 4.  Less travelled roads in clinical immunology and allergy: drug reactions and the environmental influence.

Authors:  Carlo Selmi; Chiara Crotti; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

5.  Outcome measures in pediatric polypharmacy research: a scoping review.

Authors:  Negar Golchin; Hannah Johnson; Paul M Bakaki; Neal Dawson; Elia M Pestana Knight; Sharon B Meropol; Rujia Liu; James A Feinstein; Shari D Bolen; Lawrence C Kleinman; Alexis Horace
Journal:  Drugs Ther Perspect       Date:  2019-07-12

6.  Adverse drug reaction classification by health professionals: appropriate discrimination between allergy and intolerance?

Authors:  Sepehr Shakib; Gillian E Caughey; Jie Shen Fok; William B Smith
Journal:  Clin Transl Allergy       Date:  2019-03-19       Impact factor: 5.871

7.  Diagnostic procedures & practices in drug allergy/hypersensitivity: a survey of 13 Asian countries.

Authors:  Min-Moon Tang; Jie Shen Fok; Bernard Yu-Hor Thong; James Yun; Philip Hei Li; Hye-Ryun Kang; Francis Thien; Masao Yamaguchi; Michaela Lucas; Yoon-Seok Chang; Byung-Keun Kim; Mizuho Nagao; Iris Rengganis; Yi-Giien Tsai; Wen-Hung Chung; Ticha Rerkpattanapipat; Wasu Kamchaisatian; Ting Fan Leung; Joo-Yoon Ho; Luo Zhang; Amir Hamzah Abdul Latiff; Takao Fujisawa; Mariana C Castells; Pascal Demoly; Jiu Yao Wang; Ruby Pawankar
Journal:  Asia Pac Allergy       Date:  2020-10-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.